Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Reunion Neuroscience, Inc.

Reunion Neuroscience, Inc.

Stage unknownMorristown, NJreunionneuro.comPharmaceuticals
Facts
Year of incorporation
2023sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
3
Financing history
1 rounds
  1. Jan 12, 2024
    Form D equity offering · $16.9M (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Reunion Neuroscience Management, Inc. filed Form D: $16,850,000 sold of $66,850,000, Pharmaceuticals”
Investors on record
3 edges
People
11 officers, 10 directors
Timeline
4
  1. Sep 9, 2025
    Reunion Neuroscience, Inc. filed Form D/A: $119,850,000 sold of $119,850,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. May 5, 2025
    Reunion Neuroscience, Inc. filed Form D/A: $68,880,305 sold of $89,850,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. May 6, 2024
    Reunion Neuroscience Management, Inc. filed Form D/A: $33,668,182 sold of $89,850,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. Jan 25, 2024
    Reunion Neuroscience Management, Inc. filed Form D: $16,850,000 sold of $66,850,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
65 observations
Every observation on this company